Guardion Health Sciences Inc (NASDAQ:GHSI) gapped down before the market opened on Wednesday . The stock had previously closed at $0.25, but opened at $0.24. Guardion Health Sciences shares last traded at $0.30, with a volume of 456,092 shares traded.
The business has a 50 day moving average of $1.16. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.35 and a quick ratio of 0.15.
Guardion Health Sciences (NASDAQ:GHSI) last issued its quarterly earnings data on Monday, August 12th. The company reported ($0.14) earnings per share for the quarter. Guardion Health Sciences had a negative return on equity of 212.45% and a negative net margin of 687.43%. The company had revenue of $0.26 million for the quarter.
Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Featured Article: What is Blockchain?
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.